Share on Facebook Share on Twitter Email
Answers.com

cardiac glycoside

 
Dictionary: cardiac glycoside

n.
Any of several glycosides obtained chiefly from plant sources such as the foxglove, used medicinally to increase the force of contraction of heart muscle and to regulate heartbeats.


Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
World of the Body: cardiac glycosides
Top

The introduction of the cardiac glycosides into medicine was inextricably linked to William Withering (1741-99), who studied medicine in Edinburgh and then practised in Birmingham. Like many educated people of his time, his interests were wide, and he made significant contributions to chemistry, mineralogy, and particularly botany. In 1776, he published A botanical Arrangement of all the Vegetables naturally growing in Great Britain, in two volumes which went through several later editions. His expertise in botany was put to good use when in 1775 his opinion was asked about a family recipe for the cure of dropsy, which had been kept secret by an old woman in Shropshire. He wrote:

‘I was informed that the effects produced were violent vomiting and purging … This medicine was composed of twenty or more different herbs; but it was not difficult for one conversant in these subjects to perceive that the active herb could be none other than the Foxglove.’


He found that foxglove was a powerful diuretic, but he then heard that a colleague in Oxford had cured an accumulation of fluid in the chest with it. This made him undertake a comprehensive study of foxglove, which led to the conclusion that it cured dropsy (the term then used to describe an accumulation of fluid in the tissues) due to cardiac failure, and that it led to a brisk diuresis. He published his findings on 163 cases in An account of Foxglove and some of its medical uses in 1785, in which he gave a full account of the botany, preparations, actions, and toxic effects. Of course, the poisonous actions of foxglove were already well known. Leonhard Fuchs had given a good description of the plant in 1542 and noted its action as a diuretic and laxative. However, the focus on the action in heart failure was entirely due to Withering, and represents the best early account of a rational therapeutic approach.

The main active substance in the purple foxglove Digitalis purpurea is digitoxin, a steroid (17 lactone with a trisaccharide attached at the 3 position). It is active at nanomolar concentration. Related active substances are found in D.lanata (digoxin, which is more widely used in current medical practice because of its shorter duration of action), and in Strophanthus gratus (ouabain), squill, convallaria, hellebore, and many other plants. The main effects on the heart are an increase in contractile force, especially in the failing heart, and a slowing of the rate. The slowing is particularly marked in people with atrial fibrillation, and the heartbeat is also made more regular.

All the active cardiac glycosides are inhibitors of the enzyme Na/K ATPase, present in cell membranes, which is responsible for pumping sodium out of the cell and pumping potassium in. It is generally believed that the inhibition of this enzyme is mainly responsible for the strengthening of the contraction of the heart (the resulting rise in intracellular sodium inhibits the sodium/calcium exchanger, which is the main mechanism concerned with extruding calcium from the cell; thus intracellular calcium increases, and this enhances the contractile force of the cardiac muscle). However, the action of the glycosides are complex and involve also the effects of acetylcholine and noradrenaline released from the cardiac nerves: this may be the main mechanism for reducing the heart rate. Reduction in the rate of beating of the ventricles when there is atrial fibrillation is due to a number of actions: raising of the excitation threshold at the atrio-ventricular node is probably most important (allowing fewer of the disordered waves of atrial activity to be conducted to the ventricles.) The diuretic action is probably due to inhibition of the ATPase in the kidney tubules, resulting in reduced reabsorption of sodium — and therefore also of water — from the tubular fluid, thus increasing the volume of urine.

Toxic effects include anorexia, nausea, vomiting, headache, drowsiness, and visual disturbances, as well as extrasystoles and excessive slowing of the heart rate. The dose range between therapeutic and toxic levels is small: if this were a new drug today, it is very doubtful whether it would receive approval! However, even after 200 years, cardiac glycosides remain of major importance in the treatment of heart failure.

— Arnold Burgen

See also cardiac muscle; heart; heart failure.

Medical Dictionary: cardiac glycoside
Top

n.

Any of several glycosides obtained chiefly from plant sources such as the foxglove, used medicinally to increase the force of contraction of heart muscle and to regulate heartbeats.

WordNet: cardiac glycoside
Top
Note: click on a word meaning below to see its connections and related words.

The noun has one meaning:

Meaning #1: obtained from a number of plants and used to stimulate the heart in cases of heart failure
  Synonym: cardiac glucoside


Wikipedia: Cardiac glycoside
Top

Cardiac glycosides are drugs used in the treatment of congestive heart failure and cardiac arrhythmia. These glycosides are found as secondary metabolites in several plants, but also in some animals.

Function

Cardiac glycosides are used therapeutically mainly in the treatment of cardiac failure, due to their anti-arrhythmic effects. These are caused by the ability to increase cardiac output by increasing force of contraction by prolonging the plateau phase of cardiac depolarization thus slowing ventricular contraction and allowing more time for ventricular filling. (If you increase the pre-load, you increase the force of contraction - Frank-Starling law). Drugs such as ouabain and digoxin are commonly used clinically and experimentally.

Normally, sodium-potassium pumps in the membrane of cells (in this case, cardiac myocytes) pump potassium ions in and sodium ions out. Cardiac glycosides inhibit this pump by stabilizing it in the E2-P transition state, so that sodium cannot be extruded: intracellular sodium concentration therefore increases. A second membrane ion pump, NCX, is responsible for pumping calcium ions out of the cell and sodium ions in (3Na/Ca); raised intracellular sodium levels inhibit this exchange, so calcium ions are not extruded and will also begin to build up inside the cell.

Increased cytoplasmic calcium concentrations cause increased calcium uptake into the sarcoplasmic reticulum via the SERCA2 transporter. Raised calcium stores in the SR allow for greater calcium release on stimulation, so the myocyte can achieve faster and more powerful contraction by cross-bridge cycling. The refractory period of the AV node is increased, so cardiac glycosides also function to regulate heart rate.

If SR calcium stores become too high, some ions are released spontaneously through SR ryanodine receptors. Then after-depolarization this effect leads initially to bigeminy: regular ectopic beats following each ventricular contraction. If higher glycoside doses are given, rhythm is lost and ventricular tachycardia ensues, followed by fibrillation.

Examples

Examples of plants producing cardiac glycosides:

Examples of animals producing cardiac glycosides:


 
 

 

Copyrights:

Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2009. Published by Houghton Mifflin Company. All rights reserved.  Read more
World of the Body. The Oxford Companion to the Body. Copyright © 2001, 2003 by Oxford University Press. All rights reserved.  Read more
Medical Dictionary. The American Heritage® Stedman's Medical Dictionary Copyright © 2002, 2001, 1995 by Houghton Mifflin Company Read more
WordNet. WordNet 1.7.1 Copyright © 2001 by Princeton University. All rights reserved.  Read more
Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Cardiac glycoside" Read more